Coloradomed spa & injectable regulations
What’s changing for med spas and injectors in Colorado — GLP-1 compounding, scope-of-practice, and enforcement — plus the federal FDA and Federal Register actions that apply in Colorado. Med Spa Radar monitors it all and tells you, in plain language, what changed and what to do.
Latest Colorado changes
- MONITORLegiScan2026-04-23
CO SB130: Medical Spas Deceptive Trade Practices
Colorado SB130 — pending bill on med-spa trade practices. Tracking.
- CRITICALLegiScan2025-04-07
CO HB1024: Medical-Aesthetic Services Delegation Disclosures
New disclosure requirements for delegated aesthetic services.
Federal changes that apply in Colorado
FDA and Federal Register actions are nationwide — they govern Colorado practices too.
- CRITICALFEDERALFDA Enforcement2025-09-10
FDA recall (Class II): Semaglutide, 2.5 mg/mL injection, 2 mL., Boothwyn Pharmacy
FDA recalls compounded GLP-1 product for being subpotent.
- CRITICALFEDERALFDA Enforcement2025-08-13
FDA recall (Class II): Semaglutide + Cyanocobalamin 2.67 mg + 0.25mg/0.5 mL Inj Sol, Inject 0.5 mL (50 units on syringe) subcutaneously, Steri…
FDA recalls compounded GLP-1 product; check your stock now!
- CRITICALFEDERALFDA Enforcement2026-01-07
FDA recall (Class II): Wegovy (semaglutide) Injection, 0.5 mg/0.5 mL, 4 Single-Dose Prefilled Pens, Manufactured by: Novo Nordisk A/S, DK-2880…
FDA recalls Wegovy; med spas must check supplies!
- CRITICALFEDERALFDA Enforcement2026-03-11
FDA recall (Class II): Semaglutide Inj., 2 mg x 5, Sterile Multi-Dose Vial, Rx only, Nomida, 25055 W Valley Pkwy, Suite 106, Olathe, KS 66061,…
FDA recalls Semaglutide for sterility issues—act now!
- CRITICALFEDERALFDA Enforcement2026-01-07
FDA recall (Class II): Wegovy (semaglutide) Injection, 1 mg/0.5 mL, 4 Single-Dose Prefilled Pens, Manufactured by: Novo Nordisk A/S, DK-2880 B…
FDA recalls Wegovy due to safety concerns; med spas must act.
- CRITICALFEDERALFDA Enforcement2025-07-02
FDA recall (Class II): Semaglutide, 2.5 mg/mL, pre-filled syringe, Thrive Health Solutions, 88 Inverness, Cir E, Suite A-204, Englewood, CO 80…
FDA recalls GLP-1 product over sterility issues.
What we monitor in Colorado
- Colorado legislature — bills on injectables, GLP-1s & scope of practice
- Colorado Board of Nursing — injector scope & delegation
- Colorado Medical Board — physician supervision & ownership rules
- Colorado Board of Pharmacy — compounding & 503A/503B
- U.S. FDA — enforcement, warning letters, recalls, shortages
- Federal Register — new rules on compounding & aesthetics
Colorado med spa compliance — FAQ
- Where do Colorado med spa and injectable regulations come from?
- Colorado med spas and injectors are governed by a mix of state and federal authorities — the Colorado legislature, and the state's boards of nursing, medicine, and pharmacy, alongside federal bodies like the FDA and the Federal Register. Med Spa Radar monitors all of them for Colorado and flags what changed in plain language.
- Does the FDA's GLP-1 compounding guidance apply in Colorado?
- Yes — federal FDA actions on GLP-1 compounding (semaglutide, tirzepatide) apply nationwide, including in Colorado. We track those federal changes alongside any Colorado-specific rules so you see the full picture for your practice.
- How do I keep up with Colorado regulatory changes?
- Med Spa Radar sends a free weekly Brief on what changed across Colorado, the FDA, and the Federal Register. Members get the exact "what to do" for their states in real time. It's regulatory monitoring, not legal advice.
Never miss a Colorado change
Get the free weekly Brief on what changed across Colorado, the FDA, and the Federal Register. Members get the exact what-to-do, in real time, for their states.
Get the free Brief →← All states · Regulatory monitoring, not legal advice.